We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Changes Needed to Address Inconsistent Drug Safety Message
CDER Changes Needed to Address Inconsistent Drug Safety Message
November 18, 2005
The FDA’s recently announced restructuring of the Center for Drug Evaluation and Research (CDER) should help address concerns that the FDA’s message promoting drug safety was inconsistent with the attention the issue was receiving, according to a top agency official.